Teva Pharma (TEVA) PT Lowered to $23 at Piper Jaffray, Lowers EPS Estimates

August 3, 2017 2:37 PM EDT Send to a Friend

Piper Jaffray lowered its price target on Teva Pharma (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Teva Pharma (TEVA) PT Lowered to $23 at Piper Jaffray, Lowers EPS Estimates

Member Login

Free News Feed